Modulation of dopamine D3 receptor binding by N-ethylmaleimide and neurotensin

Brain Res. 1994 Apr 18;643(1-2):343-8. doi: 10.1016/0006-8993(94)90045-0.

Abstract

GTP or G protein inactivation by N-ethylmaleimide reduced the Bmax value but not the KD value of 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin ([3H]7-OH-DPAT) binding in the rat subcortical limbic area. Neurotensin (10 nM) increased the KD and the Bmax values of [3H]7-OH-DPAT binding, and these effects persisted also following N-ethylmaleimide pretreatment. N-Propylnorapomorphine, quinpirole, raclopride, and remoxipride inhibited [3H]7-OH-DPAT binding with Ki values of 0.093, 1.97, 10.6, and 710 nM, respectively. These findings indicate that the D3 receptor is coupled to G proteins in the brain, and that neurotensin can modulate D3 agonist binding by a G protein-independent mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding, Competitive
  • Cell Membrane / metabolism
  • Dopamine Agents / pharmacology
  • Dose-Response Relationship, Drug
  • Ethylmaleimide / pharmacology*
  • Kinetics
  • Limbic System / metabolism*
  • Male
  • Neurotensin / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine / drug effects
  • Receptors, Dopamine / metabolism*
  • Receptors, Dopamine D2*
  • Receptors, Dopamine D3
  • Tetrahydronaphthalenes / metabolism

Substances

  • Dopamine Agents
  • Drd3 protein, rat
  • Receptors, Dopamine
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • Tetrahydronaphthalenes
  • Neurotensin
  • Ethylmaleimide
  • 7-hydroxy-2-N,N-dipropylaminotetralin